Literature DB >> 10493831

Refined linkage disequilibrium and physical mapping of the gene locus for X-linked dystonia-parkinsonism (DYT3).

A H Németh1, D Nolte, E Dunne, S Niemann, M Kostrzewa, U Peters, E Fraser, E Bochukova, R Butler, J Brown, R D Cox, E R Levy, H H Ropers, A P Monaco, U Müller.   

Abstract

X-linked dystonia-parkinsonism (XDP) is a recessive disorder characterized by generalized dystonia with some patients exhibiting parkinsonism. The disease gene, DYT3, is located between DXS453 (DXS993) and DXS559, and strongest linkage disequilibrium is found distal to DXS7117 and proximal to DXS559. We have isolated and analyzed four novel polymorphic markers between DXS7117 and DXS559 and, by haplotype analysis, have narrowed the candidate interval to <350 kb. A sequence-ready contig of 700 kb has been constructed spanning DXS7117 to DXS559 and is composed of 35 PACs, BACs, and cosmids. Nine genes and novel ESTs have been mapped into this contig, and mutations in the coding regions and intron-exon borders of two genes have been excluded as the cause of XDP. Several of the other genes and ESTs located within the contig code for proteins implicated in normal brain development and function and are candidates for DYT3. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493831     DOI: 10.1006/geno.1999.5929

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  20 in total

1.  The transmission/disequilibrium test and parental-genotype reconstruction for X-chromosomal markers.

Authors:  S Horvath; N M Laird; M Knapp
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

2.  Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism.

Authors:  Satoshi Makino; Ryuji Kaji; Satoshi Ando; Maiko Tomizawa; Katsuhito Yasuno; Satoshi Goto; Shinnichi Matsumoto; Maria Daisy Tabuena; Elma Maranon; Marita Dantes; Lillian V Lee; Kazumasa Ogasawara; Ikuo Tooyama; Hiroyasu Akatsu; Masataka Nishimura; Gen Tamiya
Journal:  Am J Hum Genet       Date:  2007-01-23       Impact factor: 11.025

3.  X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B.

Authors:  Christine A Vaine; David Shin; Christina Liu; William T Hendriks; Jyotsna Dhakal; Kyle Shin; Nutan Sharma; D Cristopher Bragg
Journal:  Neurobiol Dis       Date:  2016-12-22       Impact factor: 5.996

Review 4.  The emerging link between O-GlcNAcylation and neurological disorders.

Authors:  Xiaofeng Ma; He Li; Yating He; Junwei Hao
Journal:  Cell Mol Life Sci       Date:  2017-05-22       Impact factor: 9.261

Review 5.  Sex linked recessive dystonia parkinsonism of Panay, Philippines (XDP).

Authors:  L V Lee; E L Munoz; K T Tan; M T Reyes
Journal:  Mol Pathol       Date:  2001-12

6.  Identification of a novel neuroligin in humans which binds to PSD-95 and has a widespread expression.

Authors:  M F Bolliger; K Frei; K H Winterhalter; S M Gloor
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

Review 7.  Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration.

Authors:  Ilhan Akan; Stephanie Olivier-Van Stichelen; Michelle R Bond; John A Hanover
Journal:  J Neurochem       Date:  2017-11-20       Impact factor: 5.372

8.  Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations.

Authors:  Nathan Pankratz; William C Nichols; Sean K Uniacke; Cheryl Halter; Alice Rudolph; Cliff Shults; P Michael Conneally; Tatiana Foroud
Journal:  Am J Hum Genet       Date:  2002-06-07       Impact factor: 11.025

9.  Specific sequence changes in multiple transcript system DYT3 are associated with X-linked dystonia parkinsonism.

Authors:  Dagmar Nolte; Stephan Niemann; Ulrich Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-19       Impact factor: 11.205

10.  Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability.

Authors:  Niall O'Donnell; Natasha E Zachara; Gerald W Hart; Jamey D Marth
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.